An Agency for Healthcare Research & Quality comparison of two classes of antihypertensives has found that both work equally well at managing hypertension, but ACE inhibitors are linked to more dry cough than angiotensin receptor blockers.
A new Agency for Healthcare Research & Quality study has found that two classes of antihypertensives—angiotensin—converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs)-are equally effective at managing hypertension. However, of the two, ACEIs are associated with a higher incidence of dry cough than ARBs (1.7% versus 0.6%). The study, done by AHRQ's Duke University Evidence-based Practice Center, covered 16,597 patients for 12 weeks to five years. It did not examine other blood pressure medications, such as diuretics or beta-blockers. The results can be accessed at AHRQ's Effective Health Care
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.